It has been reported that a human murine mammary tumour virus (MMTV)-like virus (HMLV), which may be an endogenous human retrovirus (HERV), occurs in the human breast cancer cell lines T47D and MCF-7 and, in 38% of human breast cancer biopsies. As the aetiology of most breast cancers remains unknown, it is important to verify these observations in differing breast cancer populations worldwide. Thus, we sought to determine the genetic relationships between HMLVs, MMTVs, and HERVs, and to investigate the association between HMLVs and breast cancer biopsies from South London, UK. Phylogenetic analyses of the env/pol region indicated that HMLVs are indistinct from MMTVs, and that MMTVS/HMLVs exhibit only low sequence homologies with HERVs. A search of the human genome confirmed that HMLVs are not endogenous. Using MMTV polymerase chain reaction (PCR) primers described previously, we amplified DNA from all cell lines except MCF-7 and from 7 of 44 (16%) breast cancer biopsies. A restriction fragment length polymorphism assay was designed to distinguish between HMLVs and MMTVs, and upon analyses, PCR amplicons appeared to be HMLVs. To confirm these findings, amplicons from the T47D cell line and from four randomly selected breast cancer patients were sequenced. Of 106 DNA sequences obtained, 103 were homologous with a short arm of human chromosome (Chr) 3 (3p13), two with Chromosome 4, and one with Chromosome 8. None of the sequences exhibited significant nucleotide homology with MMTVs, HMLVs, or with HERVs (all < 50%). Thus, we conclude that (i) HMLVs are integral members of the MMTV family; (ii) MMTVs/HMLVs are genetically distinct from HERVs; (iii) MMTV/HMLV DNA is not present in human breast cancer cell lines or clinical biopsies in our locality. D
Introduction
Breast cancer is a common disease of women with 800 000 incident cases worldwide (Parkin et al., 1999) , with about 30 000 new cases diagnosed and 13 000 deaths each year in England and Wales (ONS, 1999) . This malignancy is heterogeneous with at least 16 distinct histopathological types of which ductal, lobular, and tubular are most common (Millis et al., 1999) . Important susceptibility factors for breast cancer include being female and resident in northern Europe or north America (Kelsey, 1979) , having an early menarche (Pike et al., 1981) ; a late menopause (Henderson, 1990) ; nulliparity, late prima graviditas, high socioeconomic status and exposure to ionizing radiation (Bodian, 1993; Dupont and Page, 1985; Harris et al., 1992; Kelsey and Gammon, 1991; London et al., 1992) ; a previous history of invasive carcinoma, carcinoma in situ, or atypical hyperplasia of the breast (Bodian, 1993; Dupont and Page, 1985; Harris et al., 1992; Kelsey and Gammon, 1991; London et al., 1992) ; long-term oestrogen therapy or oral contraceptive usage; obesity in postmenopausal women; and a high fat diet (Grady et al., 1992; Harris et al., 1992; Kelsey and Gammon, 1990, 1991) . However, aside from the small proportion of familial breast cancers-where inherited mutations principally in the BRCA-1 or BRCA-2 genes, are causal (Colditz et al., 1993) -the aetiology of sporadic cases of breast cancer remains unknown.
Viruses are believed to cause at least 15% of all human cancers (Butel, 2000) and recently, a viral aetiology for some cases of human breast cancer has been suggested with reports of a type B retrovirus present in malignant cells (Wang et al., 1995) . A retroviral cause for some breast tumours in mice was discovered over 60 years ago with the identification of murine mammary tumour virus (MMTV; Bittner, 1942) . Many workers then, and subsequently, have postulated that a similar virus (human MMTV-like virus, HMLV) might be causal for human breast cancers. Initial Table 4 . DNA sequences were originally obtained from data Banks, aligned, bootstrapped and the phylogenetic tree obtained using ClustalW. Bootstrap values exceeding 70% (from 1000 reiterations) are indicated, the scale bar (left) represents nucleotide difference per nucleotide (0.01 = 1 nucleotide change per 100 residues). studies supported a link between breast cancer and HMLV infection in that, MMTV-like virus particles were observed in human breast cancer biopsies (Holder and Wells, 1983) , cell lines (Segev et al., 1985) , and breast milk (Dion et al., 1987) ; expression of proteins immunologically cross-reactive with MMTV antigens were detected in human breast cancer biopsies (Segev et al., 1985) ; and there was serologic evidence of exposure to an MMTV-like agent in women with breast cancer and their healthy daughters, though rarely in control sera (Holder and Wells, 1983) . Whilst provocative, these findings were subject to the criticisms that patient numbers were often low and recruited from limited geographical locations, and that not all studies of sero-reactivity to MMTV proteins could confirm an association with malignancy (Kovarik et al., 1989) . Moreover, molecular evidence for the presence of an HMLV agent was hard to obtain.
Genetic evidence linking HMLVs with breast cancer was difficult to establish as it is unclear whether human endogenous retroviruses (HERVs) include examples of HMLVs or just exhibited sufficient nucleotide similarity to permit cross-hybridisation. HERVs constitute about 0.6% of the human genome, are randomly distributed on all chromosomes, and are often replication incompetent. Nevertheless, examples of HERV biological function have been described and some are transcriptionally active (Ting et al., 1992) . Some HERVs reportedly exhibit sequence similarities with MMTVs (Ono, 1986) and are confusingly referred to as HERVs related to MMTV (HMLs, e.g., HML-2 and HML-6). One of these (HML-2) is highly expressed in a multifocal ductal breast cancer (Yin et al., 1997) . The problem of differentiating between HERVs and HMLVs was overcome by using polymerase chain reaction (PCR) primers in the env/pol section of the MMTV provirus, as this region has low nucleotide sequence homology with a HERV-K virus (Wang et al., 1995) . Wang et al. (1995) reported that HMLV DNA occurred in 120 of 314 (38%) unselected human breast carcinomas from the USA, but in only 1 of 140 (1%) normal breast specimens from reduction mammoplasties. Similar results were obtained by Etkind et al. (2000) , who found 27 of 73 (37%) breast cancers, though not histologically normal tissues, were positive for HMLV DNA. Investigation of paraffin-embedded samples produced similar data with 36% of breast cancers from the USA (Wang et al., 1995) and 37% from Italy (Pogo et al., 1999) positive for HMLV DNA. In the last of these studies, HMLV positivity was not associated with clinical, pathological, or biological parameters other than expression of the laminin receptor, a marker for invasiveness and poorer prognosis. The same group detected HMLV RNA in 66% of DNA positive cancers by reverse transcriptase PCR (Vlahakis et al., 1998) . This HMLV appeared to be of exogenous origin as proviral DNA was present in cancerous tissue, but not in histologically normal regions of the same biopsy. Melana et al. (2001) formed a similar conclusion after they detected HMLV DNA in 32 of 106 (30%) breast cancers, but in only 1 of 106 (1%) histologically normal breast tissues.
Given the potential importance of an association between a retrovirus with some cases of human breast cancer, it is logical to determine whether these observations can be confirmed in other patient populations. We therefore investigated the genetic relationships among HMLVs, MMTVs, HMLs, and HERVs, as well as the occurrence of HMLV DNA in cell lines and in 44 human breast cancer biopsies from South London, UK.
Results

Genetic relatedness of HMLVs, MMTVs, and HERVs
We compared the env/pol region of unique isolates of these viruses archived in databanks. Phylogenetic analyses of HMLV and MMTV sequences revealed that they are closely related to one another, and that HMLVs do not form a unique 'human' branch ( Fig. 1 ): there is also a high degree of nucleotide homology (all >91%) between HMLV and MMTV sequences (Table 1) . HMLV sequence A was closely related to MMTV sequence D (98% homology), HMLV B resembled MMTV sequences F and Q (both 99%), and HMLV sequence C resembled MMTVs H and K (both 98%). Subsequent analyses demonstrated that HERVs are genetically distinct from HMLVs/MMTVs ( Fig. 2 ) and only demonstrated low homologies with HMLV (e.g., versus sequence A: all < 6%; Table 2 ), yet usually demonstrated homologies in excess of 90% with members of their own families. Similarly, HML-2 and HML-6 are 9 6 9 8 9 7 9 7 P 9 6 9 6 9 8 Q 9 8 9 8 R 9 7
These data were obtained using ClustalW after gap stripping and represent the percentage of nucleotide homology on retrieved sequences corresponding to the 656-bp section between the primers within the env/pol genes. For the accession details of these sequences, refer to Table 4. unrelated to MMTV/HMLVs and phylogenetically resemble HERVs. A BLAST search of the human genome failed to identify regions of homology with either HMLVs or MMTVs (data not shown).
PCR and RFLP analyses
We established a PCR for HMLV DNA using T47D cells and optimised the amplification conditions so that we could produce the discrete product at a lower cell number than was possible using the conditions of Etkind et al. (2000) , providing us with an assay with an analytic sensitivity of 25 T47D cells/Al. Between each breast cancer biopsy section we cut sections of apple to control for the potential carry-over of genetic material. None of the apple sections were positive for B-globin DNA or HMLV DNA, indicating that no cross-contamination had occurred. All breast cancer biopsies and all cell lines were Table 2 for the HERV sequences and their accession numbers. 3  3  3  3  3  3  3  3  3  3  3  3 3  C4  20  45 20 20  20  5  2  5  5  5  5  3  5  2  4  5  5 5  18890  96 96 96  96  6  4  2  4  6  6  3  7  4  3  6  3 6  104  97 98  3  3  2  2  4  3  3  3  3  3  3  3  3 3  103  98  98  3  3  2  4  3  3  3  3  3  3  3  3 3  108  100  3  3  2  4  3  3  3  3  3  3  3  3 3  HML2  3  3  2  4  3  3  3  3  3  3  3  3 ; HH-10 (AF108841); HH-c33 (U92820); HML6 (AF069508); HH-734E12 (AJ289710). (iii) HERV-K: HK-18.3 (AF333073); HK-18.2 (AF333069); HK-(I) (AB047209); HK-C4 (HSU07856); HK-18890 (HER18890); HK-104 (AF164612); HK-103 (AF164611); HK-108 (AF164614); HK-HML2 (AF074086). (iv) HERV-W: HW-HB9 (AB079509); HW-HB8 (AB079508); HW-HB6 (AB079506); HW-HB5 (AB079505); HW-HB2 (AB079502); HW-RT-2 (AB055416); HW-AZ521-3 (AB055413); HW-A549-2 (AB055412); HW-MCF7 (AB054088); HW-JUR3 (AB054087); HW-HepG2-2 (AB054086); HW-3-8 (AB050999); HW-C7.1 (AF156963).
positive for h-globin DNA. Every cell line-except MCF-7-was positive using MMTV primers, and of the 44 breast cancer biopsies studied, seven (16%) were repeatedly (n = 6) positive ( Figs. 3A and B ). All positive breast cancer samples were from ductal carcinomas, though there was no association with lesion grade (data not shown). RLFP testing of amplicons from cell lines and breast cancer biopsies revealed all were cut only by Msp1 (indicating that none contained MMTV DNA) and suggests that HMLV sequence B may be present (Fig. 3B ). To confirm these data, we characterised a subset of samples by DNA sequencing (below). After all PCRs, RFLP and DNA sequencing analyses of human biopsies and cell lines had been completed, we obtained MMTV DNA (ATTC plasmid p203) and were able to demonstrate that the PCR amplifies native MMTV DNA which is only sensitive to digestion by BamH1 in RFLP analyses (Fig. 3B) . A spiking experiment-using a previously MMTV-negative breast cancer biopsy sample-indicated that the PCR was able to detect between 24 and 2.4 copies of MMTV ( Fig.  4) and that the presence of breast tissue was not inhibitory when compared to the same assay run without breast tissue.
DNA Sequencing
One hundred and ten DNA sequences were obtained from T47D cells, MCF-10 cells, and from four breast cancer biopsies (Table 3) . One hundred and three sequences had high (>99%) homologies with an 'antisense' region of the short arm of human chromosome (Chr) 3 region 3p13. Irrespective of the source, all Chr3 sequences were similar to each other as illustrated phylogenetically for the 102 complete reads (Fig. 5) . Use of the NCBI Evidence Viewer revealed that the region of human Chr3 corresponding to this sequence contains no predicted mRNA exons; furthermore, the complete human DNA RP11-433A10 contig does not contain significant homology with MMTV or with HERVs (data not shown). Four sequences (MCF-10, n = 1; T47D, n = 2; biopsy #10, n = 1) were excluded from phylogenetic analyses because they either contained large numbers of ambiguity codes or contained large truncations; nevertheless, all four exhibited homology with parts of Chr3 (RP11-433A10 contig). Two sequences from biopsy #75 exhibited homologies of 97% and 99%, respectively, with a 406-bp region of human Chr4 and one from the T47D cell line with a region of human Chr8. None of the sequences exhibited significant nucleotide homology (< 50%) with MMTV, HMLV, or HERV sequences, and phylogenetic analyses indicated that these two viral groups were unrelated to Chr3 sequences. Sequencing of two cloned amplicons obtained by PCR of the MMTVcontaining plasmid (p203) revealed both contained bona fide MMTV DNA identical to sequence K AF228552: Table 4 ).
Discussion
There has recently been interest that a proportion of human breast cancers are caused by viral infection with one candidate virus being a human analogue of MMTV (Wang et al., 1995) . In this report, we have demonstrated the three reported HMLVs are integral members of the MMTV family and do not constitute a unique 'human' branch of MMTVs. This observation leads us to conclude that there is no distinct lineage of HMLVs and that they are in fact MMTVs. We next demonstrated that the MMTV/HMLV family is genetically distinct from the HERVs and that there is no significant homology between MMTV/HMLV sequences and the human genome. This result would be consistent with the proposal that HMLV has an exogenous source (Pogo et al., 1999; Wang et al., 1995) , and exhibits dissimilar epidemiological characteristics to the endogenous form of MMTV in mice. This last point is supported by epidemiological studies of humans that have demonstrated that there is no association between being breast fed as an infant and susceptibility to breast cancer in later life (Titus-Ernstoff et al., 1998) .
In this study, the same PCR primers were used as those groups that have reported HMLV in breast cancers. Amplicons were obtained for 7 of 44 (16%) breast cancer samples, but upon testing by RFLP, all contained an Msp1 site, suggesting they were similar to HMLV sequence B. However, DNA sequencing revealed that only human chromosomal DNA had been amplified and, in 96.2% of cases, this was homologous to human Chr3. Amplified Chr3 DNA sequences exhibited minor differences between clones originating from the same sample which could have arisen from: (i) hereditary differences between maternal and paternal chromosomes; (ii) host acquired mutations; and (iii) our use of Taq. DNA polymerase introduced artefacts. Nevertheless, these differences were minimal.
The explanations for the disparity between the findings of this study and those of some other groups may include the following: (i) before and during the testing of clinical samples, our laboratory had never contained MMTV, murine cell lines, or murine genetic material, consequentially, in this study, there was absolutely no potential for contamination of human samples with endogenous or exogenous MMTV DNA; (ii) HMLV may have been present in our samples, but only at low copy number. This has been suggested by Wang et al. (1995) , who used nested PCRs combined with Southern blotting to identify HMLV. Nevertheless, it is unlikely that we would not have obtained at least one HMLV sequence, given the number of DNA sequences investigated. Indeed, statistically, the 19 Chr3 sequences from the T47D cell line gives us a confidence of at least 94.7% that HMLV DNA is not present in this cell line. (iii) There may be marked, geographically, differences in the distribution of HMLV within human populations as, initially, only small patient populations in New York State, USA, and in Italy were investigated (Etkind et al., 2000; Vlahakis et al., 1998; Wang et al., 1995) . Recently, this has been highlighted in studies from Vietnam where just 1% of breast cancers were shown to be positive in PCRs for HMLV DNA, whereas in Australia the figure was 42% (Ford et al., 2003) . Conversely, an absence of MMTV has been reported in 17 ductal carcinomas despite being tested in seven MMTV PCRs (Zangen et al., 2002) and, in 50 Austrian breast cancer patients (Witt et al., 2003) . Furthermore, the latter group tested 22 human breast cancer cell lines-including T47D and MCF-7-and found none contained MMTV DNA (Witt et al., 2003) .
It might be argued that because we have used slightly different PCR conditions to Etkind et al. (2000) , the sensitivity and specificity of the PCR had been altered in such a way as to permit false priming, resulting in the amplification of host genome DNA, predominantly Chr3. However, we were subsequently able to demonstrate that our PCR conditions could amplify MMTV DNA at a higher sensitivity to those described by Etkind et al. (2000) .
We have therefore demonstrated (i) that HMLVs are members of the MMTV family and these viruses are phylogenetically distinct to the major HERV families; (ii) an absence of HMLV DNA in the T47D, MCF-7, and MCF-10 breast cancer cell lines; and (iii) the absence of MMTV/HMLV proviral DNA in breast cancer biopsies. This last finding leads us to conclude that MMTV/HMLVs are not causally involved in the aetiology of breast cancers in South London, UK, a finding that is confirmed by the recent critical observation that human cells lack the appropriate transferrin receptor for MMTV cell entry (Ross et al., 2002) .
Materials and methods
Phylogenetic and DNA analyses MMTV, HMLV, and HERV viral DNA sequences from databases were aligned with the env/pol regions corresponding to the region amplified in the PCR (below) after being gap-stripped. Alignments and phylogenetic trees were produced and bootstrapped using ClustalW (version 1.82: http://www.ebi.ac.uk/). Phylograms were visualised using TreeView (1.6.6: http://www.taxonomy. zoology.gla. ac.uk/rod/treeview.html). Experimentally derived DNA sequences were converted into the same 'sense' orientation, using the Reverse/Complimentarity programme (http:// www.ualberta.ca/%Estohard/javascript/rev _ comp.html). Sequences were then subjected to standard nucleotide 
Human cell lines
We investigated reportedly HMLV-positive (T47D cells, from a human ductal carcinoma and MCF-7 cells, an epithelial breast adenocarcinoma) and -negative (MCF-10 human epithelial cells from a patient with benign fibrocystic breast disease) cell lines for the presence of HMLVs (Wang et al., 1995) . Other human cell lines-of undetermined HMLV status-were studied and included: human embryonic kidney (HEK) cells, SiHa cells (a cervical cancer cell line), and NC37 cells (a lymphoblastoid cell line). A plasmid construct (p203) containing the env sequence of MMTV was used to check the specificity and sensitivity of the PCR. The cell lines and plasmid were obtained directly from the American Type Culture Collection (ATCC).
Biological samples
Snap-frozen biopsies of breast carcinomas from 44 female patients (median age 58, range 34 to 84 years) were randomly selected from samples collected between 1995 and 1999 in a tissue bank established by the Cancer Research U.K. Hedley Atkins Breast Pathology Laboratory, Guy's Hospital, London UK. Of the 44 patients, the majority (80%) were in situ ductal carcinomas (grade 1, 22%; grade II, 32%; and grade III, 46%), one a medullary carcinoma, one of mixed histology, and the rest were of unknown status. Permission to study these samples was provided by the Research Ethics Committee of Guy's Hospital, London. Each biopsy was mounted in OCT frozen tissue matrix and three 10-Am cryostat sections collected into an Eppendorf tube for PCR. Between each human clinical biopsy sample, the cryostat blade was cleaned with 70% (v/v) aqueous ethanol and eight 10-Am sections of frozen, OCT-mounted, apple (Malus domestica, 'Granny Smith': which contains no mammalian viruses) were cut. The last three sections of apple were subjected to PCR analyses for HMLV and h-globin DNA to control for potential 'carry over' of material between sequential human clinical samples during sectioning.
Polymerase chain reactions
All samples were treated with Proteinase K in a 20-Al volume and then 1 Al of this was subjected to PCR in a final volume of 25 Al to amplify h-globin DNA (using GH20 and PCO4 primers; Saiki et al., 1986) or HMLV DNA using MMTV primers described in the literature (Etkind et al., 
2000)
, namely, (5V! 3V ) TACATCTGCCTGTGTTAC (upstream) and CCTCACTGCCAGATC (downstream). The cycling conditions for the MMTV PCR were: 1 cycle at 94 jC for 5 min; 40 cycles at 94 jC for 30 s, 55 jC for 30 s, and 72 jC for 45 s; followed by a final extension at 72 jC for 5 min (0.5 units Thermophilus aquaticus DNA polymerase [Taq] 2.5 mM MgCl 2 , 250 AM dNTPs, and 250 nM of each primer). The h-globin PCR was included to determine if samples contained nonspecific PCR inhibitors and also to establish whether the samples contained sufficient DNA for analyses. For all PCRs, care was taken to avoid crosscontamination of biopsy samples by use of: (i) four geographically remote rooms (for reagent preparation, test sample manipulations and addition of reagents, PCR amplification, and agarose gel electrophoresis); (ii) good laboratory practice (use of plugged pipette tips and not preparing samples after dealing with amplicons on the same day); (iii) appropriate controls (one sample blank; one reagent blank; one water blank, and one aliquot of T47D cells and an equal number of apple controls per run of clinical biopsy samples); (iv) strict data acceptance criteria (all controls had to give the correct anticipated results and all human samples-but no apple sections-had to be positive for h-globin DNA, for an individual PCR 'run' to be accepted); and (v) to avoid the potential for cross-contamination, MMTV DNA was not introduced into the laboratory until all experiments on human cell lines and clinical samples had been completed. PCR products were electrophoresed into 1.8% (w/v) agarose gels containing ethidium bromide and visualised by epiillumination with UV light.
Restriction fragment length polymorphism (RFLP) analyses of PCR products
The PCR amplifies a region of the env/pol genes of MMTVs and HMLVs between nucleotides 6063 and 6719 (Fig. 6 ). The three reported HMLV DNA sequences (A, B, and C; Table 4 ) corresponding to this region should be distinguishable from one another by the presence of three restriction endonuclease (RE) cut sites: HMLV sequence A contains an Ase1 site which is not present in other documented HMLV or MMTV sequences; only sequence B contains an Msp1 site; and sequence C has a BamH1 site (as have nine MMTV sequences; Table 4 and Fig. 7) . PCR products of 25-Al volume reactions were digested with 0.5 units of RE (New England Biolabs Ltd.) for 12 h at 37 jC in the appropriate buffer. All RE were checked before use for the appropriate enzymatic activity and specificity by digesting a segment of unrelated DNA known to contain the appropriate cleavage sites.
DNA sequencing
Amplicons from HMLV PCRs were ligated into TOPO-TA (Invitrogen Ltd.), transfected into E. coli (Top10 cells; Invitrogen Ltd.), and grown overnight at 37 jC. Positive colonies were identified, inoculated into 96-well plates containing LB agar, and then sent to a commercial company (Lark Technologies Ltd.) for DNA sequencing using a T3 primer.
